Meet the Patients:
Kristen Little-Presta

IMC recently spoke with Kristen Little- Presta […]

Meet the Patients:
Biba Tinga and her family’s journey with sickle cell disease

IMC recently spoke with Biba Tinga […]

Meet the Patients:
Andrea Redway

In 2015, at the age of 47 and with no risk factors, Andrea Redway’s world […]

Meet the Patients:
Shannon Gaudette

In 2005, Shannon Gaudette, 48, was diagnosed with melanoma […]

MEET THE EXPERTS: JOE FARAGO

Joe Farago is Executive Director, Private Payers and Investment at Innovative Medicines Canada (IMC). Joe leads IMC’s efforts to take a more proactive, research-based approach to ensuring tomorrow’s workforce has […]

Happy Holidays

Innovative Medicines Canada responds to release of Patented Medicine Prices Review Board’s (PMPRB) final Guidelines

STATEMENT Ottawa, October 23, 2020 – Innovative Medicines Canada (IMC) issued the following statement today in response to the release of PMPRB’s final Guidelines: “For the last five years we have […]

Innovative Medicines Canada responds to the Trump administration’s plan to allow the importation of prescription drugs from Canada

STATEMENT Ottawa, September 25, 2020 – The following statement can be attributed to Declan Hamill, Vice President, Legal, Regulatory Affairs & Compliance, Innovative Medicines Canada in response to the Trump […]

PMPRB research fact checker

A comprehensive review of the existing body of research demonstrates that there is greater evidence of a decline […]

Innovative Medicines Canada commits to support Canada’s economic recovery while protecting Canadians’ health and well-being

Ottawa, August 12, 2020 – This fall’s federal budget will be critical in supporting Canada’s economic and social recovery. Not only will it offer an opportunity for the federal government […]